Snapshot from Aug 10, 2026 at 07:00 UTC. For live data and tracking: View Live
Business equity compensation

Ultragenyx grants inducement RSUs to new hires

Analysis based on 6 articles · First reported Nov 17, 2023 · Last updated Jul 24, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This is a routine equity compensation disclosure with minimal direct market impact. It signals continued hiring and investment in human capital but does not affect the company's financials or stock price materially.

Biotechnology

Ultragenyx Inc. (Nasdaq: RARE) reported the grant of 65,886 restricted stock units (RSUs) of its common stock to 39 newly hired non-executive officers. The awards were approved by the compensation committee and granted under the Ultragenyx Employment Inducement Plan with a grant date of July 16, 2026, as an inducement material to the new employees entering into employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs vest over four years, with 25% vesting on each anniversary of the grant date, subject to continued employment. This is a routine corporate action to attract and retain talent.

30 Ultragenyx granted restricted stock units
stock
Ultragenyx granted 65,886 RSUs to 39 new non-executive officers as an inducement, a standard practice to attract talent. The grant is dilutive but immaterial relative to total shares outstanding.
Importance 100.0 Sentiment 0.0
exch
Nasdaq is the exchange where Ultragenyx is listed; the grant complies with Nasdaq Listing Rule 5635(c)(4), but the event has no impact on the exchange itself.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.